Clinical Trial Update: O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 trial of O6-benzylguanine in combination with temozolomide for glioblastoma that did not respond to prior temozolomide and radiation; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: TERMINATED | Results posted: 2017-03-28